HRT Financial’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,127
Closed -$892K 3301
2024
Q3
$892K Buy
+21,127
New +$1.01M ﹤0.01% 1298
2024
Q1
Sell
-10,253
Closed -$365K 3144
2023
Q4
$365K Sell
10,253
-18,075
-64% -$630K ﹤0.01% 1533
2023
Q3
$949K Sell
28,328
-26,519
-48% -$919K 0.01% 1011
2023
Q2
$2.06M Sell
54,847
-7,826
-12% -$257K 0.02% 604
2023
Q1
$1.84M Buy
+62,673
New +$1.82M 0.02% 642
2022
Q4
Sell
-38,897
Closed -$902K 3201
2022
Q3
$902K Buy
38,897
+7,867
+25% +$215K 0.01% 1002
2022
Q2
$781K Buy
31,030
+11,672
+60% +$345K 0.01% 1101
2022
Q1
$739K Buy
+19,358
New +$698K 0.01% 1297
2021
Q3
Sell
-37,787
Closed -$1.98M 3785
2021
Q2
$1.98M Buy
+37,787
New +$2.15M 0.02% 628
2020
Q4
Sell
-46,316
Closed -$858K 2509
2020
Q3
$858K Buy
+46,316
New +$766K 0.02% 638

Other funds holding VCEL

HRT Financial's VCEL Position: Q4 2024 in Review

HRT Financial sold out of Vericel Corp (VCEL) in Q4 2024, closing a stake of 21,127 shares — an estimated $892K sold.

HRT Financial first reported a position in VCEL in Q3 2020 and held it in 10 quarters. The position peaked at $2.06M in Q2 2023. 278 funds tracked by Wall St. Rank hold VCEL as of Q4 2024.

  • HRT Financial reported no remaining Vericel Corp position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 21,127 Vericel Corp shares in Q4 2024, an estimated $892K.
  • HRT Financial first reported a position in Vericel Corp in Q3 2020 and held it in 10 quarters.
  • HRT Financial's Vericel Corp position peaked at $2.06M in Q2 2023.
  • 278 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.